Giannis Mountzios

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Giannis Mountzios
Jun 23, 2025, 07:10 | Blog
Giannis Mountzios Reflects on DeLLphi-304 Trial Impact on Recurrent SCLC
Giannis Mountzios, Director of the 4th Oncology Department and Clinical Trials Unit at Henry Dunant…
Jun 16, 2025, 07:20 | Blog
Giannis Mountzios: First-Ever Summer School on AI Applications in Cancer Research
Giannis Mountzios, Director of the 4th Oncology Department and Clinical Trials Unit at Henry Dunant…
Jun 15, 2025, 15:39 | Blog
IASLC Will Host Live Webinar on 2025 ASCO Highlights
International Association for the Study of Lung Cancer shared a post on LinkedIn: "2025 ASCO…
Jun 8, 2025, 16:46 | Insight
Giannis Mountzios Highlighted ASCO25 DeLLphi-304 Trial Featuring Tarlatamab Progress
Giannis Mountzios, Director of the 4th Oncology Department and Clinical Trials Unit at Henry Dunant…
Jun 6, 2025, 07:19 | Opinion
Loay Kassem: 11 Pivotal Trials From ASCO 2025 Published in The NEJM
Loay Kassem, Assistant Professor of Clinical Oncology at Kasr AlAiny School of Medicine, shared a post…
Jun 4, 2025, 03:42 | Blog
Giannis Mountzios: Α Big Lung Cancer Family Comes Together Every Year at ASCO25
Giannis Mountzios, Director of the 4th Oncology Department and Clinical Trials Unit at Henry Dunant Hospital…
Jun 3, 2025, 12:30 | Societies
15 Posts Not to Miss from the 4th Day of ASCO 2025
The ASCO Annual Meeting 2025 is officially underway in Chicago! Running from May 30 to…
Jun 3, 2025, 12:16 | Drugs
Helena Linardou: Pivotal Paper on Tarlatamab in 2nd Line SCLC by Giannis Mountzios and Colleagues
Helena Linardou, Director of the 4th Oncology Department and the Comprehensive Clinical Trials Center at…
Jun 3, 2025, 10:56 | Blog
Giannis Mountzios: ASCO25 is About Science, Research, Care but Also Your Second Family - Colleagues and Friends
Giannis Mountzios, Director of the 4th Oncology Department and Clinical Trials Unit at Henry Dunant…
Jun 3, 2025, 04:32 | Blog
Giannis Mountzios: Tony Mok Presented Herthena - Lung 03 With Patritumab DXd vs PBC in EGFR Mutation NSCLC at ASCO25
Giannis Mountzios, Director of the 4th Oncology Department and Clinical Trials Unit at Henry Dunant…
Jun 2, 2025, 15:51 | Science
Giannis Mountzios Shares Study on Molecular Determinants of Sotorasib Efficacy in KRAS G12C Mutant NSCLC
Giannis Mountzios, Director of the 4th Oncology Department and Clinical Trials Unit at Henry Dunant…
May 30, 2025, 20:40 | Blog
Giannis Mountzios: Charu Aggarwal is a Pioneer in Liquid Biopsies and Inspirational Leader
Giannis Mountzios, Director of the 4th Oncology Department and Clinical Trials Unit at Henry Dunant…
May 30, 2025, 06:35 | Blog
Jay Bradner: Molecular Determinants of Sotorasib Clinical Efficacy in KRASG12C-NSCLC
Jay Bradner, Executive Vice President of R&D, and Chief Scientific Officer at Amgen, posted on…
May 29, 2025, 14:15 | Insight
New Biomarker May Guide Best Use of KRAS Inhibitors in Lung Cancer
Lung cancer patients with high TTF-1 expression had improved survival outcomes following treatment with the…
May 27, 2025, 09:58 | Career
Giannis Mountzios: Pleased to See Noemi Reguart as a Candidate for the Chair of the ESMO Nomination Committee
Giannis Mountzios, Director of the 4th Oncology Department and Clinical Trials Unit at Henry Dunant…
May 19, 2025, 10:50 | Blog
Giannis Mountzios: DeLLphi-304 Trial on Tarlatamab vs SoC Chemotherapy in Patients with Pre-Treated SCLC at ASCO25
Giannis Mountzios, Director of the 4th Oncology Department and Clinical Trials Unit at Henry Dunant Hospital…
May 19, 2025, 10:12 | Blog
Giannis Mountzios: Join Upcoming Discussion on DLL3 T-Cell Engagers in SCLC
Giannis Mountzios, Director of the 4th Oncology Department and Clinical Trials Unit at Henry Dunant…
May 11, 2025, 13:57 | Science
Giannis Mountzios: Shedding Light on Factors Influencing Treatment Sequence in BRAF Mutant NSCLC
Giannis Mountzios, Director of the 4th Oncology Department and Clinical Trials Unit at Henry Dunant…
May 11, 2025, 11:02 | Blog
Giannis Mountzios: Can we quantify the harm-benefit ratio of adding chemo to IO in 1L advanced NSCLC?
Lung Cancer Europe shared a post by Giannis Mountzios, Director of the 4th Oncology Department…
May 4, 2025, 15:29 | Blog
Helena Linardou: Feeling Inspired and Incredibly Thankful After the ESMO Advanced Course on Early-Stage NSCLC
Helena Linardou, Director of the 4th Oncology Department and the Comprehensive Clinical Trials Center at…
Apr 30, 2025, 09:21 | Blog
Giannis Mountzios: Amazing 1st day of the ESMO Advanced Course in Early-Stage NSCLC
Giannis Mountzios, Director of the 4th Oncology Department and Clinical Trials Unit at Henry Dunant…
Apr 14, 2025, 01:50 | Blog
Giannis Mountzios: Tarlatamab Improves Overall Survival in Advanced SCLC
Giannis Mountzios, Director of 4th Oncology Department and Clinical Trials Unit at Henry Dunant Hospital…
Mar 31, 2025, 15:22 | Societies
Highlights from ELCC 2025
The European Lung Cancer Congress (ELCC) 2025 held from 26–29 March in Paris, France, brought…
Mar 30, 2025, 10:05 | Societies
Highlights from ELCC Day 4
The European Lung Cancer Congress (ELCC 2025) takes place in Paris from March 26-29, 2025, bringing together leading…
Mar 29, 2025, 17:07 | Blog
Giannis Mountzios: ELCC25 Day 4 Focuses on IO Resistance and Next-Generation ADCs
Giannis Mountzios, Director of 4th Oncology Department and Clinical Trials Unit at Henry Dunant Hospital…
Mar 29, 2025, 16:52 | Societies
Highlights from ELCC Day 3
The European Lung Cancer Congress (ELCC 2025) takes place in Paris from March 26-29, 2025, bringing together leading…
Mar 28, 2025, 16:56 | Societies
Highlights from ELCC Day 2
The European Lung Cancer Congress (ELCC 2025) takes place in Paris from March 26-29, 2025, bringing together leading…
Mar 28, 2025, 13:19 | Blog
Giannis Mountzios: Keith Kerr on the role of pathology in the optimal management of Thoracic Malignancies
Giannis Mountzios, Director of the 4th Oncology Department and Clinical Trials Unit at Henry Dunant…
Mar 27, 2025, 15:53 | Blog
Highlights from ELCC Day 1
The European Lung Cancer Congress (ELCC 2025) takes place in Paris from March 26-29, 2025,…
Mar 26, 2025, 19:20 | Blog
Giannis Mountzios: ELCC25 MARIPOSA trial - Overall Survival in 1L EGFR-mutant NSCLC
Giannis Mountzios, Director of 4th Oncology Department and Clinical Trials Unit at Henry Dunant Hospital…
Mar 26, 2025, 16:35 | Drugs
MARIPOSA trial results presented at ELCC25 - BREAKING from Paris
MARIPOSA reports OS benefit with amivantamab–lazertinib vs osimertinib monotherapy! This year, the European Lung Cancer…
Feb 22, 2025, 14:43 | Blog
Giannis Mountzios: How active ADCs against oncogene-addicted NSCLC?
Giannis Mountzios, Director of the 4th Oncology Department and Clinical Trials Unit at Henry Dunant…
Feb 18, 2025, 18:35 | Science
Giannis Mountzios: Biomarker-selected or biomarker-agnostic ADCs for oncogene-addicted NSCLC
Giannis Mountzios, Director of the 4th Oncology Department and Clinical Trials Unit at Henry Dunant…
Feb 18, 2025, 10:44 | Science
Stephanie Saw: Our review paper on ADCs in NSCLC with AGA is out
Stephanie Saw, Medical Oncologist at National Cancer Center of Singapore, reshared a post by Giannis…
Feb 7, 2025, 07:45 | Blog
The 14th Novi Sad Oncology Congress
The 14th Novi Sad Oncology Congress is scheduled to take place from February 28 to…
Feb 4, 2025, 17:23 | Societies
Giannis Mountzios: The ESMO advanced course on early-stage NSCLC will be held in Athens
Giannis Mountzios, Director of the 4th Oncology Department and Clinical Trials Unit at Henry Dunant…
Jan 27, 2025, 09:42 | Science
Giannis Mountzios: Are we treating our NSCLC patients with the optimal dose and duration of immunotherapy?
Giannis Mountzios, Director of the 4th Oncology Department and Clinical Trials Unit at Henry Dunant…
Jan 26, 2025, 12:08 | Science
Jordi Remon: De-Escalation strategies with immune checkpoint blockers in NSCLC
Jordi Remon, Thoracic oncologist at CIOCC Barcelona, shared a recent article by him and colleagues…
Jan 10, 2025, 05:59 | Insight
Results From the Phase II TROPION-Lung05 Study by Jacob Sands et al.
A recent paper by Jacob Sands, Medical Oncologist at Dana-Farber Cancer Institute, was mentioned by…
Dec 29, 2024, 10:00 | Drugs
Giannis Mountzios: 10 exciting compounds that will shape lung cancer in 2025
Giannis Mountzios, Consultant Medical Oncologist at the Department of Medical Oncology in the Air force…
Dec 20, 2024, 10:11 | Blog
Giannis Mountzios: End of story for anti-PD1/TIGIT?
Giannis Mountzios, Director of 4th Oncology Department and Clinical Trials Unit at HENRY DUNANT Hospital…
Dec 4, 2024, 00:12 | Opinion
Giannis Mountzios: A must-read Review on the ever-evolving field of EGFR mut NSCLC
Giannis Mountzios, Consultant Medical Oncologist of the 2nd Oncology Department and Clinical Trials Unit at…
Dec 2, 2024, 09:46 | Positive
Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024
As November came to a close, it's an ideal time to reflect on Lung Cancer…
Nov 6, 2024, 17:32 | Blog
Giannis Mountzios: Innovative Concepts and Global Collaborations at the ETOP Annual Meeting and Global Lung Cancer Summit
Giannis Mountzios, Consultant Medical Oncologist of the 2nd Oncology Department and Clinical Trials Unit at…
Oct 8, 2024, 01:55 | Blog
Giannis Mountzios: Anne-Marie Dingemans on novel approaches for EGFR and ALK positive disease
Giannis Mountzios, Medical Oncologist, 2nd Oncology Department and Clinical Trials Unit, Henary Dunant Hospital Center,…
Oct 6, 2024, 13:51 | Blog
The integration of cancer biomarkers allowing remarkable advancements in cancer therapeutics
Jean-Charles Soria shared a post on Linkedin: '' The integration of cancer biomarkers has revolutionized…
Oct 5, 2024, 16:04 | Societies
Highlights From ILCS24
The 6th International Lung Cancer Summit was held in Lausanne, Switzerland on October 4, 2024,…
Oct 5, 2024, 13:04 | Insight
Highlights from ILCS24 by Stephen V Liu
The 6th International Lung Cancer Summit took place as a hybrid event in Lausanne, Switzerland,…
Oct 1, 2024, 15:59 | Insight
Giannis Mountzios: How can we familiarise GPs and family doctors with new oncological therapies?
Giannis Mountzios, Medical Oncologist at the Department of Medical Oncology in the Air Force General…
Sep 25, 2024, 15:10 | Blog
Giannis Mountzios: Still confused after info/data overload from WCLC24 and ESMO24?
Giannis Mountzios, Medical Oncologist at the Department of Medical Oncology in the Air Force General Hospital,…
Sep 11, 2024, 01:59 | Societies
38 Posts Not to Miss From WCLC24 Day 3!
The WCLC24 is taking place at the San Diego Convention Center from September 7 to…
Aug 9, 2024, 14:55 | Insight
Jordi Remon: Unresolved challenges with ICB and TKIs for early stage NSCLC
Jordi Remon, a Thoracic oncologist at CIOCC Barcelona, recently posted on X: “In the current…
Aug 9, 2024, 12:23 | Blog
The 6th International Lung Cancer Summit
The 6th International Lung Cancer Summit is a hybrid conference that will be held at…
Jul 30, 2024, 02:53 | Blog
Giannis Mountzios: Huge pleasure to discuss advances in Precision oncology in NSCLC with Elsa Anagnostou and Ferdinandos Skoulidis
Giannis Mountzios, Medical Oncologist at the Department of Medical Oncology in the Air Force General…
Jul 25, 2024, 08:10 | Blog
Giannis Mountzios: A very useful prognostic tool for patients under IO
Giannis Mountzios, Medical Oncologist at the Department of Medical Oncology in the Air Force General…
Jul 25, 2024, 00:12 | Opinion
Giannis Mountzios: A fascinating update on SCLC by Triparna Sen et al.
Giannis Mountzios, Medical Oncologist at the Department of Medical Oncology in the Air Force General Hospital,…
Jun 21, 2024, 18:05 | Blog
Nature Reviews Cancer - Exploiting temporal aspects of cancer immunotherapy
Giannis Mountzios, Medical Oncologist at the Department of Medical Oncology in the Air Force General Hospital,…
Jun 21, 2024, 04:33 | Insight
Alessio Cortellini: Giannis Mountzios and I will take care of the Lung Cancer cases at the ESO MasterClass
Alessio Cortellini, Assistant Professor at Campus Bio-Medico University of Rome, shared a post on X:…
Jun 21, 2024, 04:15 | Insight
Biagio Ricciuti: Fusion partners and chromosomal breakpoints of oncogenic fusions are not stochastic
Giannis Mountzios, Medical Oncologist at the Department of Medical Oncology in the Air Force General…
Jun 2, 2024, 11:16 | Insight
Giannis Mountzios: Lorlatinib in ALK positive NSCLC sets a new benchmark in Precision Oncology
Giannis Mountzios, Medical Oncologist at the Department of Medical Oncology in the Air Force General…
May 26, 2024, 14:32 | Blog
Giannis Mountzios: A fantastic infographic by the unique Aakash Desai who did the impossible
Giannis Mountzios, Medical Oncologist at the Department of Medical Oncology in the Air Force General…
May 26, 2024, 02:56 | Blog
Giannis Mountzios: The first Vidcast for the doctor magazine in Greece focusing on lung cancer is launched
Giannis Mountzios, Medical Oncologist at the Department of Medical Oncology in the Air Force General Hospital…
May 25, 2024, 09:19 | Blog
Giannis Mountzios: Don't miss our ASCO24 session on Beyond Chemo-IO in NSCLC
Giannis Mountzios, Medical Oncologist at the Department of Medical Oncology in the Air Force General Hospital…
May 22, 2024, 13:48 | Blog
Giannis Mountzios: A great EORTC lung cancer group brain-storming meeting in sunny Malaga
Giannis Mountzios, Medical Oncologist at the Department of Medical Oncology in the Air Force General…
Apr 9, 2024, 09:03 | Insight
Giannis Mountzios: The value of post-marketing pragmatic re-assessment of new TKIs in NSCLC
Giannis Mountzios, Medical Oncologist at the Department of Medical Oncology in the Air Force General…
Mar 25, 2024, 15:15 | Societies
25 Posts Not To Miss From ELCC 2024
The European Lung Cancer Congress (ELCC 2024) took place in Prague, Czech Republic, from 20th…
Mar 25, 2024, 15:14 | Societies
Giannis Mountzios: ELCC24, Daniel Tan performs a deep dive in Bi-specific Abs/BiteS/T-cell engagers in NSCLC
Giannis Mountzios, Consultant Medical Oncologist at the Department of Medical Oncology in the Air Force…
All: 67 Posts: 1 - 100
Special Coverage